Hemostasis Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Topical Hemostasis Product, Infusible Hemostasis Product, Advanced Hemostasis Product); Application (Trauma, Surgery, Hemophilia, Myocardial Infarction, Others); End User (Hospitals, Clinics, Others)
Report Code: TIPRE00021657 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
The process of slowing and preventing the flow of blood to begin wound healing is called hemostasis. It is the mechanism that controls the bleeding from a blood vessel involving multiple interlinked steps. There are different types of hemostatic products. Gauze-based products are more adapted for wound-packing a penetrating injury; it uses active ingredient chitosan include Celox, Chito-SAM, and Hemcon. The use of Celox hemostatic granules and chitosan-impregnated gauze can instantly and safely stop blood flow from potentially lethal wounds.
MARKET DYNAMICS
Increase in the number of surgical procedures and an increase in the number of road accidents and rising prevalence of chronic diseases are the major factors for market growth. For instance, according to the American Heart Association 2019 statistics, in 2016, cardiovascular disease was known to be the leading global cause of death, accounted more than 17.6 million deaths per year, and by 2030, the death number is expected to grow to more than 23.6 million.
MARKET SCOPE
The "Hemostasis Products Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hemostasis products market with detailed market segmentation by product, application, and end user. The Hemostasis products market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Hemostasis products market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Hemostasis products market is segmented on the basis of product, application, and end user. Based on product, the market is segmented as topical hemostasis product, infusible hemostasis product, and advanced hemostasis product. Based on application, the market is segmented as trauma, surgery, hemophilia, myocardial infarction, and others. Based on end user, the market is segmented as hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Hemostasis products market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hemostasis products market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting hemostasis products market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hemostasis products market in these regions.
The report covers key developments in the hemostasis products market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Hemostasis products market are anticipated to have lucrative growth opportunities in the future with the rising demand for hemostasis products in the global market. Below mentioned is the list of few companies engaged in the Hemostasis products market.
The report also includes the profiles of key players in Hemostasis products market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and product, application, and end user s offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The process of slowing and preventing the flow of blood to begin wound healing is called hemostasis. It is the mechanism that controls the bleeding from a blood vessel involving multiple interlinked steps. There are different types of hemostatic products. Gauze-based products are more adapted for wound-packing a penetrating injury; it uses active ingredient chitosan include Celox, Chito-SAM, and Hemcon. The use of Celox hemostatic granules and chitosan-impregnated gauze can instantly and safely stop blood flow from potentially lethal wounds.
MARKET DYNAMICS
Increase in the number of surgical procedures and an increase in the number of road accidents and rising prevalence of chronic diseases are the major factors for market growth. For instance, according to the American Heart Association 2019 statistics, in 2016, cardiovascular disease was known to be the leading global cause of death, accounted more than 17.6 million deaths per year, and by 2030, the death number is expected to grow to more than 23.6 million.
MARKET SCOPE
The "Hemostasis Products Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hemostasis products market with detailed market segmentation by product, application, and end user. The Hemostasis products market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Hemostasis products market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Hemostasis products market is segmented on the basis of product, application, and end user. Based on product, the market is segmented as topical hemostasis product, infusible hemostasis product, and advanced hemostasis product. Based on application, the market is segmented as trauma, surgery, hemophilia, myocardial infarction, and others. Based on end user, the market is segmented as hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Hemostasis products market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hemostasis products market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting hemostasis products market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hemostasis products market in these regions.
The report covers key developments in the hemostasis products market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Hemostasis products market are anticipated to have lucrative growth opportunities in the future with the rising demand for hemostasis products in the global market. Below mentioned is the list of few companies engaged in the Hemostasis products market.
The report also includes the profiles of key players in Hemostasis products market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and product, application, and end user s offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Baxter International, Inc.
- C. R. Bard, Inc. (BD)
- CSL Behring LLC
- Dexur
- Grifols, S.A.
- Johnson & Johnson
- Medtronic plc
- Pfizer, Inc.
- Tricol Biomedical
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hemostasis Products Market - By Product
1.3.2 Hemostasis Products Market - By Application
1.3.3 Hemostasis Products Market - By End User
1.3.4 Hemostasis Products Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEMOSTASIS PRODUCTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEMOSTASIS PRODUCTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEMOSTASIS PRODUCTS MARKET - GLOBAL MARKET ANALYSIS
6.1. HEMOSTASIS PRODUCTS - GLOBAL MARKET OVERVIEW
6.2. HEMOSTASIS PRODUCTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HEMOSTASIS PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. TOPICAL HEMOSTASIS PRODUCT
7.3.1. Overview
7.3.2. Topical Hemostasis Product Market Forecast and Analysis
7.3.3. Collagen Market
7.3.3.1. Overview
7.3.3.2. Collagen Market Forecast and Analysis
7.3.4. Oxidized Regenerated Cellulose Market
7.3.4.1. Overview
7.3.4.2. Oxidized Regenerated Cellulose Market Forecast and Analysis
7.3.5. Gelatin Market
7.3.5.1. Overview
7.3.5.2. Gelatin Market Forecast and Analysis
7.3.6. Others Market
7.3.6.1. Overview
7.3.6.2. Others Market Forecast and Analysis
7.4. INFUSIBLE HEMOSTASIS PRODUCT
7.4.1. Overview
7.4.2. Infusible Hemostasis Product Market Forecast and Analysis
7.4.3. Fresh Frozen Plasma Market
7.4.3.1. Overview
7.4.3.2. Fresh Frozen Plasma Market Forecast and Analysis
7.4.4. Platelet Concentrate Market
7.4.4.1. Overview
7.4.4.2. Platelet Concentrate Market Forecast and Analysis
7.4.5. Factor VIII Market
7.4.5.1. Overview
7.4.5.2. Factor VIII Market Forecast and Analysis
7.4.6. Others Market
7.4.6.1. Overview
7.4.6.2. Others Market Forecast and Analysis
7.5. ADVANCED HEMOSTASIS PRODUCT
7.5.1. Overview
7.5.2. Advanced Hemostasis Product Market Forecast and Analysis
7.5.3. Flowable Complex Market
7.5.3.1. Overview
7.5.3.2. Flowable Complex Market Forecast and Analysis
7.5.4. Thrombin Complex Market
7.5.4.1. Overview
7.5.4.2. Thrombin Complex Market Forecast and Analysis
7.5.5. Fibrin Complex Market
7.5.5.1. Overview
7.5.5.2. Fibrin Complex Market Forecast and Analysis
7.5.6. Others Market
7.5.6.1. Overview
7.5.6.2. Others Market Forecast and Analysis
8. HEMOSTASIS PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TRAUMA
8.3.1. Overview
8.3.2. Trauma Market Forecast and Analysis
8.4. SURGERY
8.4.1. Overview
8.4.2. Surgery Market Forecast and Analysis
8.5. HEMOPHILIA
8.5.1. Overview
8.5.2. Hemophilia Market Forecast and Analysis
8.6. MYOCARDIAL INFARCTION
8.6.1. Overview
8.6.2. Myocardial Infarction Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. HEMOSTASIS PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. HEMOSTASIS PRODUCTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hemostasis Products Market Overview
10.1.2 North America Hemostasis Products Market Forecasts and Analysis
10.1.3 North America Hemostasis Products Market Forecasts and Analysis - By Product
10.1.4 North America Hemostasis Products Market Forecasts and Analysis - By Application
10.1.5 North America Hemostasis Products Market Forecasts and Analysis - By End User
10.1.6 North America Hemostasis Products Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hemostasis Products Market
10.1.6.1.1 United States Hemostasis Products Market by Product
10.1.6.1.2 United States Hemostasis Products Market by Application
10.1.6.1.3 United States Hemostasis Products Market by End User
10.1.6.2 Canada Hemostasis Products Market
10.1.6.2.1 Canada Hemostasis Products Market by Product
10.1.6.2.2 Canada Hemostasis Products Market by Application
10.1.6.2.3 Canada Hemostasis Products Market by End User
10.1.6.3 Mexico Hemostasis Products Market
10.1.6.3.1 Mexico Hemostasis Products Market by Product
10.1.6.3.2 Mexico Hemostasis Products Market by Application
10.1.6.3.3 Mexico Hemostasis Products Market by End User
10.2. EUROPE
10.2.1 Europe Hemostasis Products Market Overview
10.2.2 Europe Hemostasis Products Market Forecasts and Analysis
10.2.3 Europe Hemostasis Products Market Forecasts and Analysis - By Product
10.2.4 Europe Hemostasis Products Market Forecasts and Analysis - By Application
10.2.5 Europe Hemostasis Products Market Forecasts and Analysis - By End User
10.2.6 Europe Hemostasis Products Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hemostasis Products Market
10.2.6.1.1 Germany Hemostasis Products Market by Product
10.2.6.1.2 Germany Hemostasis Products Market by Application
10.2.6.1.3 Germany Hemostasis Products Market by End User
10.2.6.2 France Hemostasis Products Market
10.2.6.2.1 France Hemostasis Products Market by Product
10.2.6.2.2 France Hemostasis Products Market by Application
10.2.6.2.3 France Hemostasis Products Market by End User
10.2.6.3 Italy Hemostasis Products Market
10.2.6.3.1 Italy Hemostasis Products Market by Product
10.2.6.3.2 Italy Hemostasis Products Market by Application
10.2.6.3.3 Italy Hemostasis Products Market by End User
10.2.6.4 Spain Hemostasis Products Market
10.2.6.4.1 Spain Hemostasis Products Market by Product
10.2.6.4.2 Spain Hemostasis Products Market by Application
10.2.6.4.3 Spain Hemostasis Products Market by End User
10.2.6.5 United Kingdom Hemostasis Products Market
10.2.6.5.1 United Kingdom Hemostasis Products Market by Product
10.2.6.5.2 United Kingdom Hemostasis Products Market by Application
10.2.6.5.3 United Kingdom Hemostasis Products Market by End User
10.2.6.6 Rest of Europe Hemostasis Products Market
10.2.6.6.1 Rest of Europe Hemostasis Products Market by Product
10.2.6.6.2 Rest of Europe Hemostasis Products Market by Application
10.2.6.6.3 Rest of Europe Hemostasis Products Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hemostasis Products Market Overview
10.3.2 Asia-Pacific Hemostasis Products Market Forecasts and Analysis
10.3.3 Asia-Pacific Hemostasis Products Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Hemostasis Products Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Hemostasis Products Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Hemostasis Products Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hemostasis Products Market
10.3.6.1.1 Australia Hemostasis Products Market by Product
10.3.6.1.2 Australia Hemostasis Products Market by Application
10.3.6.1.3 Australia Hemostasis Products Market by End User
10.3.6.2 China Hemostasis Products Market
10.3.6.2.1 China Hemostasis Products Market by Product
10.3.6.2.2 China Hemostasis Products Market by Application
10.3.6.2.3 China Hemostasis Products Market by End User
10.3.6.3 India Hemostasis Products Market
10.3.6.3.1 India Hemostasis Products Market by Product
10.3.6.3.2 India Hemostasis Products Market by Application
10.3.6.3.3 India Hemostasis Products Market by End User
10.3.6.4 Japan Hemostasis Products Market
10.3.6.4.1 Japan Hemostasis Products Market by Product
10.3.6.4.2 Japan Hemostasis Products Market by Application
10.3.6.4.3 Japan Hemostasis Products Market by End User
10.3.6.5 South Korea Hemostasis Products Market
10.3.6.5.1 South Korea Hemostasis Products Market by Product
10.3.6.5.2 South Korea Hemostasis Products Market by Application
10.3.6.5.3 South Korea Hemostasis Products Market by End User
10.3.6.6 Rest of Asia-Pacific Hemostasis Products Market
10.3.6.6.1 Rest of Asia-Pacific Hemostasis Products Market by Product
10.3.6.6.2 Rest of Asia-Pacific Hemostasis Products Market by Application
10.3.6.6.3 Rest of Asia-Pacific Hemostasis Products Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hemostasis Products Market Overview
10.4.2 Middle East and Africa Hemostasis Products Market Forecasts and Analysis
10.4.3 Middle East and Africa Hemostasis Products Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Hemostasis Products Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Hemostasis Products Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Hemostasis Products Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hemostasis Products Market
10.4.6.1.1 South Africa Hemostasis Products Market by Product
10.4.6.1.2 South Africa Hemostasis Products Market by Application
10.4.6.1.3 South Africa Hemostasis Products Market by End User
10.4.6.2 Saudi Arabia Hemostasis Products Market
10.4.6.2.1 Saudi Arabia Hemostasis Products Market by Product
10.4.6.2.2 Saudi Arabia Hemostasis Products Market by Application
10.4.6.2.3 Saudi Arabia Hemostasis Products Market by End User
10.4.6.3 U.A.E Hemostasis Products Market
10.4.6.3.1 U.A.E Hemostasis Products Market by Product
10.4.6.3.2 U.A.E Hemostasis Products Market by Application
10.4.6.3.3 U.A.E Hemostasis Products Market by End User
10.4.6.4 Rest of Middle East and Africa Hemostasis Products Market
10.4.6.4.1 Rest of Middle East and Africa Hemostasis Products Market by Product
10.4.6.4.2 Rest of Middle East and Africa Hemostasis Products Market by Application
10.4.6.4.3 Rest of Middle East and Africa Hemostasis Products Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hemostasis Products Market Overview
10.5.2 South and Central America Hemostasis Products Market Forecasts and Analysis
10.5.3 South and Central America Hemostasis Products Market Forecasts and Analysis - By Product
10.5.4 South and Central America Hemostasis Products Market Forecasts and Analysis - By Application
10.5.5 South and Central America Hemostasis Products Market Forecasts and Analysis - By End User
10.5.6 South and Central America Hemostasis Products Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hemostasis Products Market
10.5.6.1.1 Brazil Hemostasis Products Market by Product
10.5.6.1.2 Brazil Hemostasis Products Market by Application
10.5.6.1.3 Brazil Hemostasis Products Market by End User
10.5.6.2 Argentina Hemostasis Products Market
10.5.6.2.1 Argentina Hemostasis Products Market by Product
10.5.6.2.2 Argentina Hemostasis Products Market by Application
10.5.6.2.3 Argentina Hemostasis Products Market by End User
10.5.6.3 Rest of South and Central America Hemostasis Products Market
10.5.6.3.1 Rest of South and Central America Hemostasis Products Market by Product
10.5.6.3.2 Rest of South and Central America Hemostasis Products Market by Application
10.5.6.3.3 Rest of South and Central America Hemostasis Products Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HEMOSTASIS PRODUCTS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HEMOSTASIS PRODUCTS MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAXTER INTERNATIONAL, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. C. R. BARD, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CSL BEHRING LLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DEXUR
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GRIFOLS, S.A.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JOHNSON AND JOHNSON
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MEDTRONIC PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PFIZER, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TRICOL BIOMEDICAL
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hemostasis Products Market - By Product
1.3.2 Hemostasis Products Market - By Application
1.3.3 Hemostasis Products Market - By End User
1.3.4 Hemostasis Products Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEMOSTASIS PRODUCTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEMOSTASIS PRODUCTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEMOSTASIS PRODUCTS MARKET - GLOBAL MARKET ANALYSIS
6.1. HEMOSTASIS PRODUCTS - GLOBAL MARKET OVERVIEW
6.2. HEMOSTASIS PRODUCTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HEMOSTASIS PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. TOPICAL HEMOSTASIS PRODUCT
7.3.1. Overview
7.3.2. Topical Hemostasis Product Market Forecast and Analysis
7.3.3. Collagen Market
7.3.3.1. Overview
7.3.3.2. Collagen Market Forecast and Analysis
7.3.4. Oxidized Regenerated Cellulose Market
7.3.4.1. Overview
7.3.4.2. Oxidized Regenerated Cellulose Market Forecast and Analysis
7.3.5. Gelatin Market
7.3.5.1. Overview
7.3.5.2. Gelatin Market Forecast and Analysis
7.3.6. Others Market
7.3.6.1. Overview
7.3.6.2. Others Market Forecast and Analysis
7.4. INFUSIBLE HEMOSTASIS PRODUCT
7.4.1. Overview
7.4.2. Infusible Hemostasis Product Market Forecast and Analysis
7.4.3. Fresh Frozen Plasma Market
7.4.3.1. Overview
7.4.3.2. Fresh Frozen Plasma Market Forecast and Analysis
7.4.4. Platelet Concentrate Market
7.4.4.1. Overview
7.4.4.2. Platelet Concentrate Market Forecast and Analysis
7.4.5. Factor VIII Market
7.4.5.1. Overview
7.4.5.2. Factor VIII Market Forecast and Analysis
7.4.6. Others Market
7.4.6.1. Overview
7.4.6.2. Others Market Forecast and Analysis
7.5. ADVANCED HEMOSTASIS PRODUCT
7.5.1. Overview
7.5.2. Advanced Hemostasis Product Market Forecast and Analysis
7.5.3. Flowable Complex Market
7.5.3.1. Overview
7.5.3.2. Flowable Complex Market Forecast and Analysis
7.5.4. Thrombin Complex Market
7.5.4.1. Overview
7.5.4.2. Thrombin Complex Market Forecast and Analysis
7.5.5. Fibrin Complex Market
7.5.5.1. Overview
7.5.5.2. Fibrin Complex Market Forecast and Analysis
7.5.6. Others Market
7.5.6.1. Overview
7.5.6.2. Others Market Forecast and Analysis
8. HEMOSTASIS PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TRAUMA
8.3.1. Overview
8.3.2. Trauma Market Forecast and Analysis
8.4. SURGERY
8.4.1. Overview
8.4.2. Surgery Market Forecast and Analysis
8.5. HEMOPHILIA
8.5.1. Overview
8.5.2. Hemophilia Market Forecast and Analysis
8.6. MYOCARDIAL INFARCTION
8.6.1. Overview
8.6.2. Myocardial Infarction Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. HEMOSTASIS PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. HEMOSTASIS PRODUCTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hemostasis Products Market Overview
10.1.2 North America Hemostasis Products Market Forecasts and Analysis
10.1.3 North America Hemostasis Products Market Forecasts and Analysis - By Product
10.1.4 North America Hemostasis Products Market Forecasts and Analysis - By Application
10.1.5 North America Hemostasis Products Market Forecasts and Analysis - By End User
10.1.6 North America Hemostasis Products Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hemostasis Products Market
10.1.6.1.1 United States Hemostasis Products Market by Product
10.1.6.1.2 United States Hemostasis Products Market by Application
10.1.6.1.3 United States Hemostasis Products Market by End User
10.1.6.2 Canada Hemostasis Products Market
10.1.6.2.1 Canada Hemostasis Products Market by Product
10.1.6.2.2 Canada Hemostasis Products Market by Application
10.1.6.2.3 Canada Hemostasis Products Market by End User
10.1.6.3 Mexico Hemostasis Products Market
10.1.6.3.1 Mexico Hemostasis Products Market by Product
10.1.6.3.2 Mexico Hemostasis Products Market by Application
10.1.6.3.3 Mexico Hemostasis Products Market by End User
10.2. EUROPE
10.2.1 Europe Hemostasis Products Market Overview
10.2.2 Europe Hemostasis Products Market Forecasts and Analysis
10.2.3 Europe Hemostasis Products Market Forecasts and Analysis - By Product
10.2.4 Europe Hemostasis Products Market Forecasts and Analysis - By Application
10.2.5 Europe Hemostasis Products Market Forecasts and Analysis - By End User
10.2.6 Europe Hemostasis Products Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hemostasis Products Market
10.2.6.1.1 Germany Hemostasis Products Market by Product
10.2.6.1.2 Germany Hemostasis Products Market by Application
10.2.6.1.3 Germany Hemostasis Products Market by End User
10.2.6.2 France Hemostasis Products Market
10.2.6.2.1 France Hemostasis Products Market by Product
10.2.6.2.2 France Hemostasis Products Market by Application
10.2.6.2.3 France Hemostasis Products Market by End User
10.2.6.3 Italy Hemostasis Products Market
10.2.6.3.1 Italy Hemostasis Products Market by Product
10.2.6.3.2 Italy Hemostasis Products Market by Application
10.2.6.3.3 Italy Hemostasis Products Market by End User
10.2.6.4 Spain Hemostasis Products Market
10.2.6.4.1 Spain Hemostasis Products Market by Product
10.2.6.4.2 Spain Hemostasis Products Market by Application
10.2.6.4.3 Spain Hemostasis Products Market by End User
10.2.6.5 United Kingdom Hemostasis Products Market
10.2.6.5.1 United Kingdom Hemostasis Products Market by Product
10.2.6.5.2 United Kingdom Hemostasis Products Market by Application
10.2.6.5.3 United Kingdom Hemostasis Products Market by End User
10.2.6.6 Rest of Europe Hemostasis Products Market
10.2.6.6.1 Rest of Europe Hemostasis Products Market by Product
10.2.6.6.2 Rest of Europe Hemostasis Products Market by Application
10.2.6.6.3 Rest of Europe Hemostasis Products Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hemostasis Products Market Overview
10.3.2 Asia-Pacific Hemostasis Products Market Forecasts and Analysis
10.3.3 Asia-Pacific Hemostasis Products Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Hemostasis Products Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Hemostasis Products Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Hemostasis Products Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hemostasis Products Market
10.3.6.1.1 Australia Hemostasis Products Market by Product
10.3.6.1.2 Australia Hemostasis Products Market by Application
10.3.6.1.3 Australia Hemostasis Products Market by End User
10.3.6.2 China Hemostasis Products Market
10.3.6.2.1 China Hemostasis Products Market by Product
10.3.6.2.2 China Hemostasis Products Market by Application
10.3.6.2.3 China Hemostasis Products Market by End User
10.3.6.3 India Hemostasis Products Market
10.3.6.3.1 India Hemostasis Products Market by Product
10.3.6.3.2 India Hemostasis Products Market by Application
10.3.6.3.3 India Hemostasis Products Market by End User
10.3.6.4 Japan Hemostasis Products Market
10.3.6.4.1 Japan Hemostasis Products Market by Product
10.3.6.4.2 Japan Hemostasis Products Market by Application
10.3.6.4.3 Japan Hemostasis Products Market by End User
10.3.6.5 South Korea Hemostasis Products Market
10.3.6.5.1 South Korea Hemostasis Products Market by Product
10.3.6.5.2 South Korea Hemostasis Products Market by Application
10.3.6.5.3 South Korea Hemostasis Products Market by End User
10.3.6.6 Rest of Asia-Pacific Hemostasis Products Market
10.3.6.6.1 Rest of Asia-Pacific Hemostasis Products Market by Product
10.3.6.6.2 Rest of Asia-Pacific Hemostasis Products Market by Application
10.3.6.6.3 Rest of Asia-Pacific Hemostasis Products Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hemostasis Products Market Overview
10.4.2 Middle East and Africa Hemostasis Products Market Forecasts and Analysis
10.4.3 Middle East and Africa Hemostasis Products Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Hemostasis Products Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Hemostasis Products Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Hemostasis Products Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hemostasis Products Market
10.4.6.1.1 South Africa Hemostasis Products Market by Product
10.4.6.1.2 South Africa Hemostasis Products Market by Application
10.4.6.1.3 South Africa Hemostasis Products Market by End User
10.4.6.2 Saudi Arabia Hemostasis Products Market
10.4.6.2.1 Saudi Arabia Hemostasis Products Market by Product
10.4.6.2.2 Saudi Arabia Hemostasis Products Market by Application
10.4.6.2.3 Saudi Arabia Hemostasis Products Market by End User
10.4.6.3 U.A.E Hemostasis Products Market
10.4.6.3.1 U.A.E Hemostasis Products Market by Product
10.4.6.3.2 U.A.E Hemostasis Products Market by Application
10.4.6.3.3 U.A.E Hemostasis Products Market by End User
10.4.6.4 Rest of Middle East and Africa Hemostasis Products Market
10.4.6.4.1 Rest of Middle East and Africa Hemostasis Products Market by Product
10.4.6.4.2 Rest of Middle East and Africa Hemostasis Products Market by Application
10.4.6.4.3 Rest of Middle East and Africa Hemostasis Products Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hemostasis Products Market Overview
10.5.2 South and Central America Hemostasis Products Market Forecasts and Analysis
10.5.3 South and Central America Hemostasis Products Market Forecasts and Analysis - By Product
10.5.4 South and Central America Hemostasis Products Market Forecasts and Analysis - By Application
10.5.5 South and Central America Hemostasis Products Market Forecasts and Analysis - By End User
10.5.6 South and Central America Hemostasis Products Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hemostasis Products Market
10.5.6.1.1 Brazil Hemostasis Products Market by Product
10.5.6.1.2 Brazil Hemostasis Products Market by Application
10.5.6.1.3 Brazil Hemostasis Products Market by End User
10.5.6.2 Argentina Hemostasis Products Market
10.5.6.2.1 Argentina Hemostasis Products Market by Product
10.5.6.2.2 Argentina Hemostasis Products Market by Application
10.5.6.2.3 Argentina Hemostasis Products Market by End User
10.5.6.3 Rest of South and Central America Hemostasis Products Market
10.5.6.3.1 Rest of South and Central America Hemostasis Products Market by Product
10.5.6.3.2 Rest of South and Central America Hemostasis Products Market by Application
10.5.6.3.3 Rest of South and Central America Hemostasis Products Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HEMOSTASIS PRODUCTS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HEMOSTASIS PRODUCTS MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAXTER INTERNATIONAL, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. C. R. BARD, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CSL BEHRING LLC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DEXUR
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GRIFOLS, S.A.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JOHNSON AND JOHNSON
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MEDTRONIC PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PFIZER, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TRICOL BIOMEDICAL
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott Laboratories
2. Baxter International, Inc.
3. C. R. Bard, Inc. (BD)
4. CSL Behring LLC
5. Dexur
6. Grifols, S.A.
7. Johnson & Johnson
8. Medtronic plc
9. Pfizer, Inc.
10. Tricol Biomedical
11. Hemostasis, LLC
12. Sysmex Europe GmbH
13. Olympus Corporation
14. Siemens Healthineers
15. Merit Medical Systems
1. Abbott Laboratories
2. Baxter International, Inc.
3. C. R. Bard, Inc. (BD)
4. CSL Behring LLC
5. Dexur
6. Grifols, S.A.
7. Johnson & Johnson
8. Medtronic plc
9. Pfizer, Inc.
10. Tricol Biomedical
11. Hemostasis, LLC
12. Sysmex Europe GmbH
13. Olympus Corporation
14. Siemens Healthineers
15. Merit Medical Systems
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
GET FREE SAMPLE PDF
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount